Evidence map›Paper›PMID 29463582›Full record

ArticlePediatrics2018

Infant Hospitalizations and Mortality After Maternal Vaccination.

Lakshmi Sukumaran, Natalie L McCarthy, Elyse O Kharbanda, Gabriela Vazquez-Benitez, Heather S Lipkind, Lisa Jackson, Nicola P Klein, Allison L Naleway, David L McClure, Rulin C Hechter and 3 more

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Association Between COVID-19 Vaccination During Pregnancy and Safety Among Infants.Journal of the Pediatric Infectious Diseases Society · 2026
    Article
  6. Review
  7. Safety and Clinical Benefits of AdacelInfectious diseases and therapy · 2023
    Review
  8. Maternal vaccination-current status, challenges, and opportunities.The journal of obstetrics and gynaecology research · 2023
    Review
  9. Vaccinations in pregnancy.Obstetrics, gynaecology and reproductive medicine · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Lakshmi SukumaranImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia; lsukumaran@cdc.gov.
Natalie L McCarthyImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia.
Elyse O KharbandaHealthPartners Institute, Minneapolis, Minnesota.
Gabriela Vazquez-BenitezHealthPartners Institute, Minneapolis, Minnesota.
Heather S LipkindDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, Yale University, New Haven, Connecticut.
Lisa JacksonKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Nicola P KleinDivision of Research, Kaiser Permanente of Northern California, Oakland, California.
Allison L NalewayCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
David L McClureMarshfield Clinic Research Institute, Marshfield, Wisconsin.
Rulin C HechterDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Alison T KawaiDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and.
Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
Eric S WeintraubImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia.
Kaiser Permanente · USCenters for Disease Control and Prevention · USHealthPartners · USHarvard University · USKaiser Permanente Center for Health Research · USKaiser Permanente Washington Health Research Institute · USMarshfield Clinic · USNational Center for Immunization and Respiratory Diseases · USYale University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundThe Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines. There are limited studies of the long-term safety in infants for vaccines administered during pregnancy. We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life.

methodsWe included singleton, live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014. Outcomes were infant hospitalizations and mortality in the first 6 months of life. We performed a case-control study matching case patients and controls 1:1 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza and/or Tdap vaccines in pregnancy.

resultsThere were 413 034 live births in our population. Of these, 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life. We found no association between infant hospitalization and maternal influenza (adjusted odds ratio: 1.00; 95% confidence interval [CI]: 0.96-1.04) or Tdap (adjusted odds ratio: 0.94; 95% CI: 0.88-1.01) vaccinations. We found no association between infant mortality and maternal influenza (adjusted odds ratio: 0.96; 95% CI: 0.54-1.69) or Tdap (adjusted odds ratio: 0.44; 95% CI: 0.17-1.13) vaccinations.

conclusionsWe found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life. These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy.

Indexed as

Infant MortalityCase-Control StudiesCause of DeathDiphtheria-Tetanus-acellular Pertussis VaccinesFemaleHospitalizationHumansInfantInfant, NewbornInfluenza VaccinesPregnancyPregnancy Complications, InfectiousRespiratory Tract DiseasesRisk FactorsUnited StatesVaccinationDiphtheria-Tetanus-acellular Pertussis VaccinesInfluenza Vaccines

Identifiers

PMID29463582
PMCPMC6586222
OpenAlexW2792735656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.